Effects of alcohol-induced dysregulation of lung hyaluronic acid
酒精引起的肺透明质酸失调的影响
基本信息
- 批准号:10686267
- 负责人:
- 金额:$ 4.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-07 至 2024-09-06
- 项目状态:已结题
- 来源:
- 关键词:Acute Respiratory Distress SyndromeAffectAlcoholic Liver DiseasesAlveolarAlveolar MacrophagesAnti-Inflammatory AgentsAntibodiesAntioxidantsAreaAsthmaAttenuatedBioenergeticsBiogenesisBiologyBronchoalveolar Lavage FluidCD44 AntigensCD44 geneCOVID-19 pneumoniaCarbohydratesCellsCessation of lifeChronicDNA copy numberDataElectrophoresisEnergy MetabolismEnzyme-Linked Immunosorbent AssayEthanolExtracellular MatrixFluorescenceFluorescence MicroscopyFunctional disorderGrantHeavy DrinkingHyaluronic AcidHyaluronidaseImmuneImmune responseImmunityImpairmentIn VitroInflammationInflammation MediatorsInflammatoryInvestigationLigandsLinkLower respiratory tract structureLungLung diseasesMacrophageMeasuresMediatingMembrane ProteinsMesenchymal Stem CellsMetabolismMicrobiologyMitochondriaMitochondrial DNAModelingModificationMolecularMolecular WeightMorbidity - disease rateMusOxidation-ReductionOxidative StressOxidative Stress InductionPPAR gammaPathologyPathway interactionsPatientsPatternPhagocytesPhagocytosisPioglitazonePneumoniaPolysaccharidesPropertyReactive Oxygen SpeciesRespiratory Tract InfectionsRiskRoleSignal PathwaySignal TransductionStructure of parenchyma of lungTechniquesTestingTherapeuticTimeTrainingalcohol effectalcohol exposurealcohol misusealcohol use disordercell motilitychronic alcohol ingestionchronic respiratory diseaseextracellularfluorophoreimmune functionin vivoin vivo Modelinsightlung injurymolecular dynamicsmortalitynovelnovel therapeuticsoxidant stresspathogenpharmacologicpneumocytepreventprotein expressionrecruitresponserestorationtherapeutic targettraining opportunitytranslational modeluptakewound healing
项目摘要
PROJECT SUMMARY/ABSTRACT
Ethanol (EtOH) misuse is linked to over 5 million annual deaths globally, partly due to increased risk of
developing respiratory infections and acute respiratory distress syndrome. Alveolar macrophages (AM), the
first line of defense against pathogens in the lower respiratory tract, have impaired bioenergetic and phagocytic
capabilities following chronic alcohol exposure. EtOH increases oxidative stress in the alveolar space and
mitochondrial (MT)-derived oxidative stress in AM. Chronic oxidative stress disrupts redox signaling and
induces molecular damage. Hyaluronic acid (HA) is an extracellular matrix polysaccharide produced in the
alveolar space by pneumocytes and resident macrophages. Although evidence suggests that AM immunity
and HA molecular weight/function are each negatively influenced by oxidative stress, their interactions have
never been explored in the context of alcohol misuse. The objective of the proposed studies is to investigate
the underlying mechanisms of EtOH-induced AM dysfunction due to intra- and extracellular oxidative stress.
These studies will focus specifically on EtOH-induced redox imbalance and its effect on HA synthesis,
degradation, and inflammatory signaling in the AM. Mechanistic studies will explore if perturbed HA synthesis,
degradation, or signaling impact mitochondrial function and energy metabolism. Our overarching hypotheses
is that EtOH-induced oxidative stress and altered MT function impair AM phagocytic capabilities by
modulating HA dynamics.
To test our hypothesis, we will use established murine in vitro and in vivo chronic EtOH consumption
models to determine how HA modulates MT bioenergetics and AM phagocytosis and how EtOH-induced
oxidative stress modulates HA dynamics. Aim 1 studies will focus on the effects of HA binding proteins and
downstream signaling pathways on expression of key MT regulators, MT bioenergetics, and AM phagocytosis.
Aim 2 studies will focus on how EtOH-induced lung redox imbalance results in HA disruptions in the AM. Lung
HA concentrations will be correlated with AM oxidative stress. EtOH-induced lung oxidative stress and AM MT-
derived oxidative stress will be targeted using pioglitazone, a peroxisome proliferator-activated receptor
gamma ligand with antioxidant properties. The role of HA in EtOH-induced AM dysfunction is unexplored and
significant in delineating this pathology. Novel pathways identified in these studies could shift scientific and
therapeutic paradigms by identifying perturbed HA dynamics as a therapeutic target. This proposal will provide
an invaluable training opportunity for the applicant and provide potential therapeutic strategies to target HA
dynamics to prevent EtOH-induced impairments in AM phagocytosis and resultant pulmonary injury. These
studies are not only important to investigate the mechanisms of impaired lung immunity due to alcohol misuse
but may also provide valuable insights into HA derangements in several other pulmonary diseases including
coronavirus disease 2019, pneumonia, and asthma.
项目摘要/摘要
乙醇(ETOH)滥用与全球500万人死亡有关,部分是由于增加的风险
发展呼吸道感染和急性呼吸窘迫综合征。肺泡巨噬细胞(AM),
在下呼吸道中针对病原体的第一道防线,生物能和吞噬性受损
慢性酒精暴露后的能力。 ETOH增加肺泡空间中的氧化应激和
线粒体(MT)衍生的氧化应激。慢性氧化应激破坏了氧化还原信号传导和
诱导分子损伤。透明质酸(HA)是在中产生的细胞外基质多糖
肺细胞和常驻巨噬细胞的肺泡空间。尽管有证据表明是免疫力
和HA分子量/功能/功能都受氧化应激的负面影响,它们的相互作用具有
在滥用酒精的背景下从未探索过。拟议研究的目的是调查
由于细胞内和细胞外氧化应激引起的ETOH诱导的AM功能障碍的基本机制。
这些研究将专门集中于EtOH诱导的氧化还原不平衡及其对HA合成的影响,
AM中的降解和炎症信号传导。机械研究将探索是否扰动HA合成,
降解或信号传导影响线粒体功能和能量代谢。我们的总体假设
EtOH诱导的氧化应激和MT功能的改变会损害AM吞噬能力
调节HA动力学。
为了检验我们的假设,我们将在体外和体内使用已建立的鼠类消耗量
确定HA如何调节MT生物能学和AM吞噬作用以及EtOH诱导的模型
氧化应力调节HA动力学。 AIM 1研究将侧重于HA结合蛋白和
关键MT调节剂,MT生物能学和AM吞噬作用的下游信号通路。
AIM 2研究将重点介绍ETOH诱导的肺氧化还原不平衡如何导致AM中的HA中断。肺
HA浓度将与AM氧化应激相关。 EtOH诱导的肺氧化应激和mt-
衍生的氧化应激将使用Pioglitazone(一种过氧化物酶体增殖物激活受体)靶向
具有抗氧化特性的伽马配体。 HA在ETOH诱导的AM功能障碍中的作用未开发,并且
对描述这种病理意义很重要。这些研究中确定的新途径可能会改变科学和
通过识别扰动的HA动力学作为治疗靶标,治疗范例。该建议将提供
申请人的宝贵培训机会,并提供潜在的治疗策略来针对HA
动力学以防止ETOH诱导的AM吞噬作用和导致肺损伤的损伤。这些
研究不仅很重要,对于因酒精滥用而导致的肺免疫力受损机制很重要
但也可能会提供有关其他几种肺部疾病中HA危险的宝贵见解
2019年冠状病毒病,肺炎和哮喘。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kathryn Marie Crotty其他文献
Kathryn Marie Crotty的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kathryn Marie Crotty', 18)}}的其他基金
Effects of alcohol-induced dysregulation of lung hyaluronic acid
酒精引起的肺透明质酸失调的影响
- 批准号:
10614953 - 财政年份:2021
- 资助金额:
$ 4.77万 - 项目类别:
Effects of alcohol-induced dysregulation of lung hyaluronic acid
酒精引起的肺透明质酸失调的影响
- 批准号:
10389703 - 财政年份:2021
- 资助金额:
$ 4.77万 - 项目类别:
相似国自然基金
脂肪组织中SIRT3通过抑制外泌体miR-30a-3p调控肝脏自噬影响非酒精性脂肪肝病的机制研究
- 批准号:32360174
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
支链氨基酸及其代谢产物通过调控胆固醇代谢影响非酒精性脂肪性肝病的进展
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
非酒精性脂肪性肝病对心肌梗死后修复和重构的影响:肝脏外泌体来源miRNA的关键作用
- 批准号:82270342
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
支链氨基酸及其代谢产物通过调控胆固醇代谢影响非酒精性脂肪性肝病的进展
- 批准号:32200965
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
BaP通过激活AhR调控FGF-21和雄激素受体影响非酒精性脂肪肝病的机制研究
- 批准号:82260733
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
相似海外基金
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
- 批准号:
10761044 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
Integrating Treatments for Alcohol Use Disorder into Hepatology Clinics
将酒精使用障碍的治疗纳入肝病诊所
- 批准号:
10785211 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
Role of Interferon-Gamma / Interleukin-12 Axis in Metabolic Liver Disease
干扰素-γ/白介素-12 轴在代谢性肝病中的作用
- 批准号:
10735419 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
Asian American Prevention Research: A Populomics Epidemiology Cohort (ARISE)
亚裔美国人预防研究:人口组学流行病学队列 (ARISE)
- 批准号:
10724884 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
Developing tools for calcium imaging in ITPR2-linked liver pathogenesis
开发 ITPR2 相关肝脏发病机制的钙成像工具
- 批准号:
10727998 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别: